Laura A Dawson, MD, FRCPC

Dr. Dawson’s research interests include implementation of advanced radiation technologies (e.g. stereotactic body radiation therapy (SBRT), image guidance, including MRI guided radiation therapy) to improve outcomes and to reduce the risk of toxicity in patients receiving radiation therapy. She also investigates novel uses of radiation therapy, such as SBRT for the treatment of liver cancer, and novel combinations of therapies such as SBRT and immunotherapy. She is also interested in innovations that reduce the risk of radiation related toxicities. She is the principal investigator of two randomized phase III clinical trials investigating the use of radiation therapy in patients with primary liver cancer (hepatocellular carcinoma) and/or liver metastases, and she is an investigator on other local trials investigating radiation therapy with or without immunotherapy.

For a list of Dr. Dawson's publications, please visit PubMed or Scopus.

Member, Institute of Medical Science, University of Toronto
Staff Radiation Oncologist, Radiation Medicine Program, Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto